English | Español

Regeneron Pharmaceuticals Inc. PAC (Regeneron PAC)
Carol Ostrow | Sep 23, 2017

Study shows Dupixent reduces symptoms of atopic dermatitis

Trending
+ Pharmaceuticals
Patient Daily | Sep 12, 2025

Taxpayers Protection Alliance says 340B program is driving up taxpayer costs
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
Patient Daily | Sep 15, 2025

Physician assistant on sinus issues and sleep disruption: ‘Any kind of sinus issue will always affect your sleep’
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Study finds exercise-produced molecule may help reduce appetite through brain pathways